FDA Enables Generic Insulins with Lower Prices
Insulin Nation
MARCH 26, 2020
The FDA Commissioner, Stephen M. These critical therapies often carry a heavy price tag; the cost of insulin has risen over the past decade. In other words: any pharmaceutical companies will be legally allowed to produce more affordable versions of today’s most advanced insulins. “ FDA Goals for New Regulatory Framework.
105 
Let's personalize your content